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ABSTRACT
Many therapeutically active drugs are poor water soluble and, 
therefore, bioavailability of these molecules in the living cells 
is low and a major problem. In this study, new-generation 
Jeffamine® D230 core, amine (NH2), Tris(hydroxymethyl) 
aminomethane (TRIS), and carboxyl (COOH) terminated 
poly(amidoamine) PAMAM dendrimers (PAMAMs) were 
synthesized. Synthesized new-generation PAMAMs were 
characterized by 1H NMR, 13C NMR, ATR-FTIR, and 
investigated as solubility enhancer of a sample non-steroidal 
anti-inflammatory drug (NSAID) Ibuprofen (IBU). The effect 
of generation size (D2-D4), concentration (0-2.0 mM), and 
surface functional group (NH2, COOH, TRIS) of the synthesized 
new-generation PAMAMs on the aqueous solubility of IBU was 
also investigated. The observed solubility enhancement of IBU 
was in the order of D4.COOH (18.21 mg/mL)> D3.COOH 
(13.21 mg/mL)> D4.TRIS (10.30 mg/mL)> D2.COOH (8.55 
mg/mL)> D3.TRIS (6.04 mg/mL)> D4.NH2 (4.56 mg/mL)> 
D3.NH2 (3.36 mg/mL)> D2.TRIS (2.42 mg/mL)> D2.NH2 (1.86 
mg/mL). Results showed that synthesized PAMAMs improved 
the solubility of IBU significantly (30 to 247-fold) with an 
increasing generation size, and concentration.
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1. Introduction
The therapeutic efficacy of a drug in an appropriate dose 
might decrease due to its inadequate access to the target 
site of action in the body. To overcome this problem, drug 
is usually given high doses to the body to show the desired 
impact. Disappearance of the remedial effectiveness of 
drug substances stems from the low solubility of drug 
pharmaceutical ingredients in the aqueous environment of 
the human body. Results of the studies conducted in medicinal 
chemistry have shown that water-soluble derivatives of the 
chemical formulations of drugs can be prepared successfully; 
however, even small constructional changes in the structure 
may lead to the dramatic decreases in their efficacy (1).
Drug carriers are defined as any substances incorporating 
to improve the delivery and the effectiveness of drugs (2). 
Various drug carrier systems such as liposomes, micelles, 
nanoparticles, and nanorods are used to perform the 
desired release of the drugs having weak solubility and 
therefore, low bioavailability in the body, and to minimize 
the interaction of the drugs with the healthy tissues (3). 
Regarding these systems, the main encountered drawbacks 
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are instability within the body, interaction with the healthy 
tissues, allowing absorption in the kidneys due to nano sizes, 
and thus, expelling out the blood circulation (4, 5). To avoid 
these handicaps, dendrimers can take over as potential drug-
delivery systems (6).
Among drug carriers systems, poly(amidoamine) (PAMAM) 
dendrimers (PAMAMs) take an important role not only with 
their controllable size, structures, and surface functional 
groups, but also with the presence of large internal 
cavities, which serve as hosts for many poor soluble active 
pharmaceutical ingredients (APIs) (7). Core, repeated 
branches, and type of surface functional groups of PAMAMs 
are the main factors besides their generation, concentration, 
and pH media to improve the solubility of drugs. Due to 
these properties of PAMAMs, they have great advantages 
in the solubilization and controlled release of many poor 
soluble pharmaceuticals such as anticancer, antimalarial, 
antiviral, antitubercular, antimicrobials, non-steroidal anti-
inflammatory (NSAIDs) and anti-hypertensive (8-12).
Over the last decades, although PAMAMs have gained much 
interest in new applications in pharmaceutical chemistry, 
there still exists reports about the cytoxicity and hemolotic 
toxicity of amine-terminated PAMAMs (PAMAM-NH2) 
(8, 13). To get rid of the mentioned toxicity and gain bio-
compatibility, surface modification of cationic PAMAM-NH2 
dendrimers with anionic or neutral functional groups 
have been presented (14, 15). Results of these studies have 
shown that carboxyl-terminated PAMAMs (PAMAM-
COOH), in particular, have been found to be less toxic than 
cationic PAMAM-NH2 dendrimers (16). On the other hand, 
Twyman et al. (17) were synthesized Tris(hydroxymethyl)
aminomethane (TRIS) terminated PAMAMs (PAMAM-
TRIS) as an alternative to PAMAM-COOH in order to use 
them as drug-delivery systems. The result of their study 
has showed that PAMAM-TRIS dendrimers increased the 
solubility of small hydrophobic acidic drugs. However, 
commercial unavailability, laborious synthesis with three 
to four-day reaction times, and tedious purification steps 
when DMSO used as solvent limited the potential use and 
investigation of PAMAM-TRIS dendrimers as drug carriers 
for a wide spectrum of poor soluble drugs. In our recent study 
(18), we have developed a fast, easy and one-pot microwave-
assisted synthesis method for the synthesis of PAMAM-TRIS 
dendrimers. During synthesis, higher product yields (90-
96%) and short reaction times (110-140 min) were observed 
under mild reaction conditions using methanol as solvent. 
Therefore, higher opportunity of using of PAMAM-TRIS 
dendrimers as potential drug-delivery systems for the future 
studies and clinical applications has been provided (18). 
Here, we focus on using neutral PAMAM-TRIS dendrimers 
as potential drug carriers for NSAIDs by using Ibuprofen 
(IBU) as a sample model drug, and comparing their 
solubilization properties with cationic PAMAM-NH2 and 
anionic PAMAM-COOH dendrimers.
In the current study, new-generation Jeffamine® D230 (D) 
core NH2, TRIS, and COOH-terminated D2-D4 PAMAMs 
were synthesized. Synthesized new types of PAMAMs 
were characterized by 1H NMR, 13C NMR, ATR-FTIR, 
spectroscopic titrations, and investigated solubility enhancer 
of a sample NSAIDs group member drug IBU. On the basis 
of this aim, the effect of concentration, generation size (D2-
D4), and surface functional group (NH2, COOH, TRIS) 
of Jeffamine® D230 (D) cored PAMAMs on the aqueous 
solubility of IBU (Fig. 1) was also in investigated.
2. Materials and methods
2.1. Materials and apparatus
Jeffamine® D230 (D), methyl acrylate, EDA, TRIS, methanol, 
n-butanol, NaOH, CuSO4 and IBU were obtained from 
Sigma-Aldrich (St. Louis, Missouri, USA). All other 
chemicals were of analytical grade and used without further 
purification. All solutions were prepared by using Milli-Q 
deionized water (Merk Millipore Corporation, Billerica, 
Massachusetts, USA). The ATR-FTIR spectra (4000–400 
cm−1) were recorded with a Bruker spectrometer (Ettlingen, 
Germany). UV-Vis spectra were recorded with PG TG 70 
((Leicestershire, UK). NMR measurements were performed by 
using a Bruker 500 MHz spectrometer (Ettlingen, Germany). 
Synthesis System, model Discover (CEM Corporation, 
North Carolina, USA) with a continuous microwave power 
delivery system with operator selectable power output from 
0 to 300 W (±30 W) programmable in 1-watt increments, 
infrared temperature control system programmable from 
25 to 250 oC, and 5 to 125 mL vessel capacity was used as 
microwave reactor. Spectroscopic titrations were carried out 
automatically by using TitroLine® 7000 ((SI Analytics GmbH, 
Hattenbergstrabe, Germany)) autotitrator equipped with 
thermostated titration vessel under nitrogen media.
2.2. Synthesis of PAMAMs
Microwave-assisted synthesis of PAMAM-NH2 (D2.NH2-D4.
NH2) and PAMAM-TRIS (D2.TRIS-D4.TRIS) dendrimers 
with (D) core, from half generation PAMAM-OCH3 
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dendrimers were performed according to our previous 
studies (19) and (18), respectively. On the other hand, half 
generation ester terminated PAMAMs (PAMAM-OCH3) 
(D1.5 OCH3-D3.5.OCH3) were converted to PAMAM-
COOH dendrimers (D2.COOH-D4.COOH) by using the 
slight modification of the literature procedure (20) and our 
recent study (13) (Scheme 1). Purity of the synthesized new 
type of PAMAMs was characterized by ATR-FTIR, 1H NMR, 
13C NMR and, supported by spectroscopic titrations. Some 
physico-chemical properties of the synthesized PAMAMs 
were presented in Table 1.
2.2.1. General procedure for the microwave-assisted 
synthesis PAMAM-NH2 dendrimers
Jeffamine® D230 (D) cored PAMAM-NH2 dendrimers were 
synthesized according to our previous study (19), and briefly 
summarized hereafter. This method involves the alkylation 
(a) and amidation (b) steps (Scheme 1). In the alkylation 
steps, a methanolic solution of methyl acrylate (2.5 M eq. 
per terminal amine) was added over to a stirring methanolic 
solution of dendrimer core (D) Jeffamine® D230 (D) or full 
generation PAMAM-NH2 dendrimers (Dn.NH2). After 
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Scheme 1. Synthetic routes for higher generation PAMAM-NH2, PAMAM-TRIS and PAMAM-COOH dendrimer synthesis.
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stirring the resulting reaction mixture for 24 h at room 
temperature, excess reagents and solvents were removed 
under vacuum at 65 oC and purified by means of LPR. 
The resulting PAMAM-OCH3 dendrimers (Dn.5.OCH3) 
D0.5.OCH3-D3.5.OCH3 were colorless oils and product 
yields were between 95-98% (Table 2).
D0.5. OCH3
Yellowish gel (12.22 g, 96%). ATR-IR vmax/cm-1 1739 
(C=O). 1H-NMR δH(500 MHz; CDCI3) 2.38 (8H, t, 
CH2CH2COOCH3), 2.75 (8H, m, CH2CH2COOCH3), 3.25 
(4H, m, OCH2CH2NR2), 3.62 (12H, s, COOCH3). 13C-NMR 
δC(125 MHz; CDCI3) 173.05 (COOCH3), 77.36, 77.10, 76.85 
(OCH2CH2O), 51.36 (COOCH3), 46.34 (CH2CH2COOCH3), 
34.46 (CH2CH2COOCH3).
D1.5. OCH3
Yellowish gel (16.55 g, 95%). ATR-IR vmax/cm-1 3331 (NH), 1731 
(C=O), 1647 (HNC=O), 1545 (HNC=O). 1H-NMR δH(500 
MHz; CDCI3) 2.34 (16H, m, CH2CH2COOCH3), 2.43 (16H, m, 
CH2CH2COOCH3), 2.67 (8H, m, CONHCH2CH2NR2), 3.57 
(24H, s, COOCH3). 13C-NMR δC(125 MHz; CDCI3) 172.90 
(COOCH3), 172.35 (NCH2CH2CONH), 51.52 (COOCH3), 
49.17 (CH2CH2COOCH3), 32.59 (CH2CH2COOCH3).
D2.5. OCH3
Yellowish gel (17.91 g, 96%). ATR-IR vmax/cm-1 3305 (NH), 1732 
(C=O), 1645 (HNC=O), 1538 (HNC=O). 1H-NMR δH(500 
MHz; CDCI3) 2.28 (32H, m, CH2CH2COOCH3), 2.46 (32H, m, 
CH2CH2COOCH3), 2.71 (16H, m, CONHCH2CH2NR2), 3.57 
(48H, s, COOCH3). 13C-NMR δC(125 MHz; CDCI3) 172.95 
(COOCH3), 172.06 (NCH2CH2CONH), 51.58 (COOCH3), 
49.19 (CH2CH2COOCH3), 32.62 (CH2CH2COOCH3).
D3.5.OCH3
Yellowish gel (10.72 g, 98%). ATR-FTIR vmax/cm-1 3294 
(NH), 1731 (C=O), 1644 (HNC=O), 1537 (HNC=O). 
1H-NMR δH(500 MHz; CDCI3) 2.29 (64H, m, 
CH2CH2COOCH3), 2.48 (64H, m, CH2CH2COOCH3), 2.70 
(32H, m, CONHCH2CH2NR2), 3.61 (96H, s, COOCH3). 
Table 1. Some physico-chemical properties of the synthesized PAMAMs (See also Scheme 1).
Dendrimer Mwa
(g/mol)
Number of tertiary 
amines (NR3)
Number of terminal 
amines (NH2)
Number of terminal 
hydroxyls (OH)
Number of terminal 
carboxyl (COOH)
NH2-terminated
D2.NH2
D3.NH2
D4.NH2
1600
3427
7081
6
14
30
8
16
32
-
-
-
-
-
-
TRIS-terminated
D2.TRIS
D3.TRIS
D4.TRIS
2088
4403
9034
6
14
30
-
-
-
24
48
96
-
-
-
Carboxyl-terminated
D2.COOH
D3.COOH
D4.COOH
1263
2753
5734
6
14
30
-
-
-
-
-
-
8
16
32
aMolecular weight
Table 2. Preparition of Jeffamine® D230 core ester-terminated PAMAM dendrimers (Dn.5).
PAMAM-OCH3
dendrimers
R-NH2
g (mmol)
MA g,
(mmol)
MeOH
(mL)
Time
(h)
Yield
(%)
D0.5.OCH3 5.1 (22.17) 9.54 (110) 30 24 96
D1.5.OCH3 8.7 (12.66) 10.90 (126) 30 24 95
D2.5.OCH3 10.03 (6.26) 10.79 (125) 30 24 96
D3.5.OCH3 6.07 (1.77) 6.09 (70) 30 24 98
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13C-NMR δC(125 MHz; CDCI3) 173.02 (COOCH3), 
172.05 (NCH2CH2CONH), 51.59 (COOCH3), 49.19 
(CH2CH2COOCH3), 32.62 (CH2CH2COOCH3).
In the amidation steps, a 1-5 mL methanolic solution of 
ethylenediamine (EDA) involving 10 M eq. of excess EDA 
per ester branched PAMAM-OCH3 dendrimers were added 
to a vigorously stirring methanolic solution of half generation 
PAMAM-OCH3 dendrimers (Cn.5). The final mixture was 
irradiated with microwave (MW) at 250 W for 80 min. Final 
traces of EDA were removed under vacuum below a bath 
temperature of 65 oC by the azeotrapic mixture of n-butanol 
three times. The resulting product was purified by using 
LPR. The final products were full generation PAMAM-NH2 
dendrimers (Dn.NH2) D1.NH2-D4.NH2. Product yields were 
in the range of 90-97% (Table 3).
D1.NH2
Yellowish gel (11.81 g, 97%). ATR-IR vmax/cm-1 3286 (NH), 
1642 (HNC=O), 1553 (HNC=O). 1H-NMR δH(500 MHz; 
DMSO-d6) 2.20 (8H, m, CH2CH2CONH), 2.56 (16H, m, 
CH2CH2CONH), 2.80 (8H, s, CONHCH2CH2NH2), 3.04 
(8H, t, CONHCH2CH2NH2), 8.09 (4H, s, NCH2CH2CONH). 
13C-NMR δC(125 MHz; DMSO-d6) 171.51 
(NCH2CH2CONH), 74.38, 74.16, 74.05 (OCH2CH2O), 45.43 
(NCH2CH2CONH), 43.05 (CONHCH2CH2NH2), 41.83 
(CONHCH2CH2NH2), 35.91 (NCH2CH2CONH).
D2.NH2
Yellowish gel (13.23 g, 90%). ATR-IR vmax/cm-1 3281 (NH), 
1644 (HNC=O), 1550 (HNC=O). 1H-NMR δH(500 MHz; 
DMSO-d6) 2.21 (16H, m, CH2CH2CONH), 2.57 (16H, 
m, CH2CH2CONH), 2.68 (16H, m, CONHCH2CH2NH2), 
3.03 (16H, m, CONHCH2CH2NH2), 8.02 (8H, s, 
NCH2CH2CONH). 13C-NMR δC(125 MHz; DMSO-d6) 
171.49 (NCH2CH2CONH), 45.48 (NCH2CH2CONH), 43.02 
(CONHCH2CH2NH2), 41.89 (CONHCH2CH2NH2), 35.96 
(NCH2CH2CONH).
D3.NH2
Yellowish gel (13.42 g, 90%). ATR-IR vmax/cm-1 3271 (NH), 
1654 (HNC=O), 1566 (HNC=O). 1H-NMR δH(500 MHz; 
D2O) 2.25 (32H, m, CH2CH2CONH), 2.58 (32H, m, 
CH2CH2CONH), 2.64 (32H, m, CONHCH2CH2NH2), 3.13 
(32H, m, CONHCH2CH2NH2). 13C-NMR δC(125 MHz; 
D2O) 171.42 (NCH2CH2CONH), 45.54 (NCH2CH2CONH), 
43.06 (CONHCH2CH2NH2), 41.83 (CONHCH2CH2NH2), 
35.91 (NCH2CH2CONH).
D4.NH2
Yellowish gel (4.81 g, 93%). ATR-IR vmax/cm-1 3275 (NH), 
1634 (HNC=O), 1548 (HNC=O). 1H-NMR δH(500 MHz; 
D2O) 2.25 (64H, m, CH2CH2CONH), 2.57 (64H, m, 
CH2CH2CONH), 2.64 (64H, m, CONHCH2CH2NH2), 3.12 
(64H, m, CONHCH2CH2NH2). 13C-NMR δC(125 MHz; 
D2O) 174.90 (NCH2CH2CONH), 47.04 (NCH2CH2CONH), 
44.38 (CONHCH2CH2NH2), 41.22 (CONHCH2CH2NH2), 
35.87 (NCH2CH2CONH).
2.2.2. General procedure for the microwave-assisted 
synthesis of PAMAM-TRIS dendrimers
PAMAM-TRIS dendrimers were prepared according to 
procedure in our recent study (18), and briefly summarized 
hereafter. A methanolic solution of PAMAM–OCH3 
dendrimers (D1.5.OCH3-D3.5.OCH3) were added to a 
stirred suspension of TRIS (1.2 M equiv. per terminal ester) 
and anhydrous K2CO3 (1.5 M equiv. per terminal ester) in 
10–15 mL of MeOH. The following mixture was irradiated at 
200 W for 120–130 min by refluxing at a bulk temperature of 
70–90 oC. The final reaction mixture was filtered to remove 
excess solid reagents, and the filtrate collected. Then product 
Table 3. Preparition of Jeffamine® D230 core amine-terminated PAMAM dendrimers (Dn.NH2).
PAMAM-NH2
dendrimers
R-OCH3
g (mmol)
EDA
g (mol)
MeOHa
(mL)
MW
(watt)
Time
(min)
Yield
(%)
D1.NH2 10.19 (17.74) 42.65 (0.79) 5.0 200 80 97
D2.NH2 12.64 (9.19) 44.18 (0.73) 5.0 200 80 90
D3.NH2 12.68 (4.25) 40.94 (0.68) 5.0 200 80 90
D4.NH2 4.53 (0.73) 14.09 (0.23) 5.0 200 80 93
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was purified with the LPR method. The final methanolic 
solution of retained product (Dn.TRIS) was concentrated 
under vacuum below a bath temperature of 65 oC, The 
resulting products were D2.TRIS-D4.TRIS, and yields were 
in the range of 92–95% (Table 4).
D2.TRIS
Opaque oil (1.27 g, 94%). ATR-IR vmax/cm-1 3272 (COH), 
1645 (HNC=O), 1567 (HNC=O), 1395 (O-H). 1H NMR 
δH(500 MHz; D2O) 2.57 (16H, m, CH2CH2CONHCR3), 
2.72 (16H, m, CH2CH2CONHCR3), 3.67 (48H, s, CH2OH). 
13C NMR δC(125 MHz; D2O) 181.12, 174.62, 174.46 
(NCH2CH2CONH), 62.06 (CONHCR2CH2OH), 56.43 
(CONHCR2CH2OH), 50.32 (CH2CH2CONHCR3), 33.21 
(CH2CH2CONHCR3).
D3.TRIS
Opaque oil (1.29 g, 95%). ATR-IR vmax/cm-1 3288 (COH), 
1647 (HNC=O), 1569 (HNC=O), 1396 (O-H). 1H NMR 
δH(500 MHz; D2O) 2.58 (32H, m, CH2CH2CONHCR3), 
2.79 (32H, m, CH2CH2CONHCR3), 3.73 (96H, s, CH2OH). 
13C NMR δC(125 MHz; D2O) 181.01, 174.82, 174.66 
(NCH2CH2CONH), 62.26 (CONHCR2CH2OH), 56.51 
(CONHCR2CH2OH), 50.70 (CH2CH2CONHCR3), 33.34 
(CH2CH2CONHCR3).
D4.TRIS
Opaque oil (1.24 g, 92%). ATR-FTIR vmax/cm-1 3292 (COH), 
1649 (HNC=O), 1571 (HNC=O), 1396 (O-H). 1H NMR 
δH(500 MHz; D2O) 2.55 (64H, m, CH2CH2CONHCR3), 
2.76 (64H, m, CH2CH2CONHCR3), 3.70 (192H, s, CH2OH). 
13C NMR δC(125 MHz; D2O) 181.92, 174.49, 174.23 
(NCH2CH2CONH), 62.53 (CONHCR2CH2OH), 56.94 
(CONHCR2CH2OH), 50.41 (CH2CH2CONHCR3), 33.15 
(CH2CH2CONHCR3).
2.3.3. General procedure for the synthesis of PAMAM-
COOH dendrimers
PAMAM-COOH dendrimers were prepared by slight 
modification of literature procedure (20) and our previous 
recent study (13). A methanolic solution of ester-terminated 
half generation PAMAM-OCH3 (Dn.OCH3) was mixed with 
1.5 M equiv. of NaOH per terminal ester. The final mixture 
was stirred for 24 h. Excess amount of solvent was removed 
under vacuum at bath temperature 65 oC. The remaining oil 
was dissolved in methanol and again evaporated in vacuo. 
Drying under vacuum resulted in a white powder product. 
The resulting products were D2.COOH-D4.COOH, and 
yields were 100% (Table 5.)
D2.COOH
White solid (0,54 g, 100%). ATR-IR vmax/cm-1 3299 (COOH), 
1647 (HNC=O), 1569 (HNC=O), 1402 (O-H). 1H NMR 
Table 4. Preparition of Jeffamine® D230 core TRIS-terminated PAMAM dendrimers (Dn.TRIS).
PAMAM-TRIS
dendrimers
R-OCH3
g (mmol)
TRIS
g (mmol)
K2CO3
g (mmol)
MeOH
(mL)
MW
(watt)
Time
(min)
Yield
(%)
D2.TRIS 0.9 (0.65) 0.75 (6.2) 1.1 (7.97) 10.0 200 130 94
D3.TRIS
D4.TRIS
0.94 (0.31)
0.98 (0.15)
0.72 5.95)
0.69 (5.7)
1.02 (7.39)
0.99 (7.17)
10.0
10.0
200
200
150
140
95
92
Table 5. Preparition of Jeffamine® D230 core carboxyl-terminated PAMAM dendrimers (Dn.COOH).
PAMAM COOH
Dendrimers
R-OCH3
g (mmol)
NaOH
g (mmol)
MeOH
(mL)
Time
(h)
Yield
(%)
D2.COOH 0.64 (0.43) 0.2 (5.15) 5.0 24 100
D3.COOH
D4.COOH
0.44 (0.15)
0.88 (0.14)
0.14 (3.6)
0.27 (6.87)
4.0
4.0
24
24
100
100
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δH(500 MHz; D2O) 2.29 (16H, bm, CH2CH2COOH), 2.56 
(16H, bm, CH2CH2COOH). 13C NMR δC(125 MHz; D2O) 
181.21, 181.06 (COOH), 174.38 (NCH2CH2CONH), 48.94 
(CH2CH2COOH), 34.03 (CH2CH2COOH).
D3.COOH
White solid (0,41 g, 100%). ATR-IR vmax/cm-1 3309 (COOH), 
1650 (HNC=O), 1573 (HNC=O), 1405 (O-H). 1H NMR 
δH(500 MHz; D2O) 2.23 (32H, bm, CH2CH2COOH), 2.59 
(32H, m, CH2CH2COOH). 13C NMR δC(125 MHz; D2O) 
181.23, 181.17 (COOH), 174.64 (NCH2CH2CONH), 48.79 
(CH2CH2COOH), 34.12 (CH2CH2COOH).
D4.COOH
White powder (0.8 g, 100%). ATR-FTIR vmax/cm-1 3305 
(COOH), 1641 (HNC=O), 1566 (HNC=O), 1398 (O-H). 1H 
NMR δH(500 MHz; D2O) 2.28 (64H, bm, CH2CH2COOH), 
2.68 (64H, bm, CH2CH2COOH). 13C NMR δC(125 MHz; 
D2O) 181.01, 180.68 (COOH), 174.68 (NCH2CH2CONH), 
48.86 (CH2CH2COOH), 33.86 (CH2CH2COOH).
2.3. The spectroscopic titrations of PAMAM-COOH and 
PAMAM-TRIS dendrimers with Cu2+ ions
Spectrocopic titrations were conducted on the synthesized 
PAMAM-TRIS and PAMAM-COOH dendrimers to 
characterize and show the structural monodispersity 
or homogeneity by using a PG-70 batch type UV-Vis 
instrument. UV measurements were conducted within the 
wavelength range of 400-900 nm with a 10 mm quartz UV 
cells. The spectroscopic titrations experiments were carried 
out according to our previous work (18). In summary, Table 
6 presents the concentrations of dendrimer and CuSO4 
solutions used in the spectroscopic titration.
2.4. Preparation and characterization of drug-PAMAM 
dendrimer complexes
2.4.1. Preparation of drug-PAMAM dendrimer complexes
Preparation of IBU-PAMAM dendrimer complexes were 
performed according to literature procedures (21, 22) and 
mentioned hereafter briefly. The initial molar rations of IBU to 
dendrimer were 1:1. The reaction mixtures were stirred at 250 
rpm and 37 oC for 24 h. Then, a rotary evaporator was used to 
remove methanol. The precipitates were dried under vacuum 
to remove the methanol completely, followed by the addition 
of deionized water and stirred for another 2 h to extract out 
drug-dendrimer complex. This solution then filtered through 
the 0.45 µm and lyophilized to remove the water completely. 
Resulting drug-dendrimer complex was subjected to ATR-
FTIR (4000-600 cm-1) and UV-Vis (230-400 nm) analysis.
2.4.2.. UV-Vis characterization
IBU-PAMAM dendrimer complexes were diluted properly 
with methanol to the final concentration of 10 µg/mL. The 
UV spectra of these complexes were collected between 
the wavelength ranges of 210-400 nm. λmax = 221 nm was 
observed to be the maximum absorption band. Any shift 
Table 6. Concentrations used to titrate aqueous solutions of TRIS and COOH terminated PAMAMs with Cu2+ ions.
Type of Dendrimer Dendrimer conc.
(mM)
CuSO4 conc.
(mM)
Increment of CuSO4
(µL)
D4.TRIS 0.301 66.25 630.00
D4.COOH 0.320 66.25 697.00
Table 7. Number of tertiary amine groups on PAMAM-TRIS and PAMAM-COOH dendrimers available for binding with 
Cu2+ ionsa
Type of Dendrimer 3N theoretical value 3N practical value % Correlation
D4.TRIS 30 28.55 ± 0.78 95.16
D4.COOH 30 28.92 ± 0.69 96.40
aResults were calculated from potentiometric titrations for five repeated experiments, and presented as mean ± confidence intervals.
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or suppression in this strong band was assigned to complex 
formation (21-24).
2.4.3. ATR-FTIR spectral studies
PAMAM-COOH dendrimer, IBU, and IBU-PAMAM drug-
dendrimer complexes were subjected to ATR-FTIR. The 
FTIR spectra were recorded after 20 scans at 4 cm-1 in a 
wavenumber range of 4000-600 cm-1.
2.5. Solubility tests of drugs
The solubility of drugs was determined by using the rotating 
bottle technique of Higuchi and Connors (25). 5 mL aqueous 
solutions of PAMAMs with different generation size (D2-
D4), surface functional groups (NH2, COOH, TRIS), and 
molar concentration (0-2 mM) were prepared. Then, excess 
amounts of drugs were added to each PAMAM dendrimer 
solution. The resulting suspensions were shaken at 250 rpm 
and 37 oC for 24 h. Then, the solutions were centrifuged at 
6000 rpm for five minutes, and insoluble excess drugs was 
removed by filtering through 0.45 µm cellulose acetate 
filter. The absorbances of the test solutions and PAMAMs 
were measured by PG T-70 UV-Vis spectrophotometer 
in the characteristic wavelength (λmax = 221 nm for IBU). 
Absorbances of PAMAMs were subtracted from drug-
dendrimer test solution absorbances. The absorbances were 
Figure 2. Sample representative ATR-FTIR spectra of D3.NH2, D3.5.OCH3, D4.COOH D4.TRIS PAMAM dendrimers.
Figure 1. Molecular structure and some physicochemical 
properties of IBU: λmax = 221 nm, pKa = 4.85 Mw = 206.3 
g/mol
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correlated with the calibration curve prepared for drugs 
and the amount of drugs were determined. Three repeated 
measurements were conducted.
3. Results and discussion
3.1. Characterization of PAMAMs
Conversion of PAMAM-OCH3 dendrimers to PAMAM-NH2, 
PAMAM-COOH and PAMAM-TRIS dendrimers were 
followed by ATR-FTIR, 1H NMR, and 13C NMR spectra. In the 
ATR-FTIR characterization, replacement of amide I (~1640 
cm-1) and amide II (~1540 cm-1) peaks, and disappearance 
of ~1730 cm-1 peak originating from the ester functional 
groups of PAMAM-OCH3 dendrimers evidenced to the fully 
conversion of PAMAM-OCH3 dendrimers to PAMAM-NH2 
dendrimers (Fig.2) . Similar observation were obtained for 
PAMAM-OCH3 to PAMAM-COOH and PAMAM-TRIS 
dendrimer conversions. Moreover formation of new band 
at 3500-3100 cm-1 was assigned as OH part of carboxylic 
acid and TRIS, which could readily make H-Bond resulting 
broadening the spectrum (Fig. 2).
Fig. 3 shows a representative sample NMR monitoring 
spectra of the conversion of D3.5 to D4. COOH and D4.TRIS 
dendrimers as an example to PAMAM-OCH3 to PAMAM-
COOH and PAMAM-TRIS dendrimers. Investigation of the 
Fig. 3 reveals that methyl ester peak of D3.5.OCH3 at 3.61 
ppm cannot be observed in the spectra of D4.COOH and 
D4.TRIS, and confirms the complete conversion of ester 
groups to acids (D4.COOH, middle in Fig. 3). In addition, 
formation of a new singlet peak of D4.TRIS at 3.70 ppm 
affirms the full modification of the ester functional groups 
to TRIS (D4.TRIS, top in Fig. 3). On the other hand, the 
fully disappearance of the methy ester peak of D3.5 at 51.59 
ppm during the synthesis of D4.COOH and D4.TRIS was 
observed. Instead, a new peak at 56.94 ppm (NHCR3) and 
62.53 pmm (-CH2OH) were appeared at TRIS conversions. 
This was also an indication of good purity. In addition, the 
signals at 181.92 from exterior amides (C=O), and 174.23, 
174.49 ppm from interior amides (C=O) correspond to TRIS, 
and the interior amides prove the complete conversion of 
D3.5 to D4.TRIS. Moreover, formation of the 181.01, 180.68, 
174.68 ppm corresponding to acids and interior amides 
proves the fully conversion of D3.5.OCH3 to D4.COOH. 
Thus, 1H NMR and 13C NMR spectroscopy evaluations 
prove good purity. Similar results were observed in the NMR 
monitoring of the all conversions from PAMAM-OCH3 
dendrimers to synthesized PAMAM-COOH and PAMAM-
TRIS dendrimers.
Figure 3. 1H NMR spectrum monitoring of the conversion 
of Jeffamine core PAMAMs (D3.5.OCH3 in CDCI3, 
D4.COOH and D4.TRIS in MeOD).
3.2. Spectroscopic characterization and the determination 
of the number of tertiary amine groups present in 
PAMAM-COOH and PAMAM-TRIS dendrimers
3.3. Spectroscopic characterization of IBU-PAMAM 
dendrimer complexes
Spectroscopic titration experiments were conducted according 
to our recent study (18) by simply adapting from Crooks et. 
al former studies (26, 27). The results of these studies showed 
that Cu2+ ions coordinate with a maximum number of four 
tertiary amines. In similar, our aim in this study was to show 
the ideal growth of the synthesized PAMAM dendrimers and 
monodispersity by calculating the exact number of tertiary 
amines present at D4.TRIS and D4.COOH with the aid of 
spectroscopic titrations. After addition of Cu2+ ions at the 
specific increments (Table 6) to the dendrimer solutions, 
a sudden change in color to deep blue was observed. The 
intensity of this color was dependent on Cu(II)-PAMAM-
COOH and Cu(II)-PAMAM-TRIS dendrimers complexes of 
D4.COOH and D4.TRIS characterized with a broad absorption 
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a
b
Figure 4. Absorption spectra of PAMAM-COOH dendrimers at 680 nm (a) D4.COOH (0.320 mM) solution titrated with 
Cu2+ (66.25 mM), and (b) spectroscopic titration curve of D4.COOH.
band at λmax 680 nm in UV-Vis spectrophotometer (Fig. 4 and 
Fig. 5). This band (copper d-d transition) is the indication 
of complexation between Cu(II), and the tertiary amine 
groups of dendrimers at 1:4 molar ratio and coordination 
(28). The maximum molar excess of Cu2+ that can be loaded 
onto PAMAM–TRIS and PAMAM-COOH dendrimers were 
determined from absorbance at λmax 680 nm versus Cu2+/
PAMAM–TRIS and Cu2+/PAMAM-COOH dendrimers molar 
ratio plots (Fig. 4 and Fig. 5).
Table 7 presents the theoretical number of tertiary amines 
(3N) present in PAMAM-TRIS and PAMAM-COOH 
dendrimers (D4.TRIS and D4.COOH) and the experimental 
found numbers. The results showed that there exist a good 
correlation between theoretical and practical number of 
tertiary amine numbers in PAMAM-TRIS and PAMAM-
COOH dendrimers. These results are also evidence for the 
purity, monodispersity therefore ideal growth of synthesized 
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PAMAM dendrimers with no such kind of impurity like 
trailing generations.
3.3.1. UV-Vis characterization
Fig. 6 shows the UV-Vis spectra of IBU, PAMAM dendrimer, 
IBU-PAMAM dendrimer complexes in methanol. The λmax of 
IBU is 221 nm and PAMAMs is ~280 nm. The suppression of 
the 221 nm band in the spectrum of alone and IBU-PAMAM 
dendrimer complexes indicates that the bonding between 
among dendrimer-drug molecules could be attributed to 
non-covalent interactions or entrapping of drug molecules 
to the cavity of dendrimers (29).
a
b
Figure 5. Absorption spectra of PAMAM-TRIS dendrimers at 680 nm (a) D4.TRIS (0.301 mM) solution titrated with Cu2+ 
(66.25 mM), and (b) spectroscopic titration curve of D4.TRIS.
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Figure 6. UV-spectra of (1) IBU (10 µg/mL); (2) IBU-D4.
COOH complex (10 µg/mL); (3) IBU-D4.TRIS complex (10 
µg/mL); (4) IBU-D4.NH2 complex (10 µg/mL); (5) D4.TRIS 
(25 µM); (6) 25 µM D4.NH2 (25 µM); (7) D4.COOH (25 µM).
Figure 7. ATR-FTIR spectra of (1) IBU; (2) IBU-D4.COOH complex, and (3) D4.COOH
3.3.2. ATR-FTIR characterization
ATR-FTIR spectra of the IBU, D4.COOH, and IBU-D4.
COOH complex were recorded between 4000-600 cm-1, and 
presented in Fig. 7. Characteristic bands of IBU were found 
at 2954 and 2867 cm-1 (C-H strecthing); 1704 cm-1 (C=O 
stretching); 1429 (C-H strecthing) and 1230 cm-1 (C-O 
stretching). The ATR-FTIR spectrum of pure D4.COOH 
showed about at 3270 cm-1, 3000-2800 cm-1, 1645 cm-
1, 1560 cm-1, 1402 cm-1, and at 1031 cm-1 corresponding 
to the vibrations of O-H stretching, C-H stretching, C=O 
stretching, N-H bending, C-O stretching, and C-O stretch 
groups, respectively. After complexation of PAMAMs 
with IBU, spectral shifts were observed for the dendrimer 
characteristic bands at between 0-15 cm-1 because of the 
hydrophilic interactions with dendrimer polar groups
3.4. Effect of dendrimer concentration and generation on 
the solubility of IBU
The effect of dendrimer concentration and generation size 
on the aqueous solubility of IBU was studied by using (D) 
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core and NH2, TRIS and COOH-terminated PAMAMs, and 
the results were shown in Fig. 8. Results showed that the 
solubility of IBU enhanced significantly in the presence of 
PAMAMs with an increasing generation size (D2-D4) and 
dendrimer concentration (0-2 mM). Form these results, 
it could be concluded that the encapsulation efficiency of 
PAMAMs increases especially by the increasing generation 
size and varying functional groups, which could be attributed 
to dendrimer trapping the drugs by electrostatic interaction, 
and encapsulation of the inner cavities of dendrimers (30).
3.5. Effect of surface functional group on solubility of IBU
Presence of high density of surface functional groups in the 
structure of PAMAMs make them attractive for solubility 
enhancement applications of poor soluble drugs in aqueous 
media. Inner cavities and surface functionality of PAMAMs 
are responsible for increased solubility and, therefore, they 
can be acceptable as suitable drug-delivery systems (13). 
Up to know, the best reported solubility enhancement for 
IBU was obtained when EDA cored generation 4 amine-
terminated PAMAM dendrimer (7.45 (mg/mL) (31) and β 
CD (~ 0.96 mg/mL) (32) ecepients used. IBU is practically 
water insoluble (0.08 mg/ml). As shown in Fig. 8, the solubility 
of IBU was increased significantly in comparison with the 
before mentioned literature in the presence of D4.COOH 
(18.21 mg/mL), D3.COOH (13.21 mg/mL), D4.TRIS (10.30 
mg/mL), D2.COOH (8.55 mg/mL). The observed solubility 
enhancement was in the decreasing order of D4.COOH 
(18.21 mg/mL)> D3.COOH (13.21 mg/mL)> D4.TRIS 
(10.30 mg/mL)> D2.COOH (8.55 mg/mL)> D3.TRIS (6.04 
mg/mL)> D4.NH2 (4.56 mg/mL)> D3.NH2 (3.36 mg/mL)> 
D2.TRIS (2.42 mg/mL)> D2.NH2 (1.86 mg/mL), and in 
the ranges of 30 to 247-fold. Overall, results indicated that 
that the solubility of IBU increased with the increasing 
generation number of all NH2, TRIS, and COOH-terminated 
PAMAM dendrimers. Water-soluble TRIS and COOH-
terminated PAMAM dendrimers synthesized in this study 
could be potential drug carriers for NSAIDs for the future 
clinal applications and biological studies by eliminating the 
disadvantages of amine-terminated PAMAMs without 
causing any lysis of the living cells.
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Figure 8. Solubility profiles of IBU in the presence of 
increasing generation and concentrations of COOH, TRIS, 
and NH2-terminated PAMAMs.
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ÖZ
Birçok terapötik olarak aktif olan ilaçların sudaki çözünürlüğü 
zayıf ve bundan dolayı canlı hücrelerde biyoyararlanımları 
düşük ve büyük bir problem oluşturmaktadır. Bu çalışmada, 
yeni nesil Jeffamine® D230 çekirdekli amin (NH2), 
Tris(hidroksimetil)aminometan (TRIS) ve karboksil (COOH) 
sonlu poli(amidoamine) PAMAM dendrimerler (PAMAMs) 
sentezlendi. Sentezlenen yeni tip PAMAMs’lar 1H NMR, 13C 
NMR, ATR-FTIR kullanılarak karakterize edildi ve örnek bir 
non-steroidal anti-inflamatuar ilaç (NSAID) olan Ibuprofen 
(IBU) için çözünürlük arttırıcı olarak araştırıldı. Sentezlenen 
yeni nesil PAMAMs’ların, jenerasyon büyüklüğünün (D2-D4), 
konsantrasyonun (0-2.0 mM) ve yüzey fonksiyonel gruplarının 
(NH2, COOH, TRIS), IBU’nun çözünürlüğüne olan etkisi ayrıca 
araştırıldı. IBU’nun gözlemlenen çözünürlük artışı, D4.COOH 
(18.21 mg/mL)> D3.COOH (13.21 mg/mL)> D4.TRIS (10.30 
mg/mL)> D2.COOH (8.55 mg/mL)> D3.TRIS (6.04 mg/mL)> 
D4.NH2 (4.56 mg/mL)> D3.NH2 (3.36 mg/mL)> D2.TRIS 
(2.42 mg/mL)> D2.NH2 (1.86 mg/mL) sırasındadır. Sonuçlar 
gösteriyor ki, sentezlenen PAMAMs’ların jenerasyon büyüklüğü 
ve konsantrasyonun artmasıyla birlikte IBU’nu çözünürlüğü 
önemli ölçüde artmıştır (30 ile 247 kat arası).
Anahtar kelimeler: Dendrimer, poly(amidoamin) PAMAM, 
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